Alternatively, suppressing whole-body BCAA oxidation in mice by deleting PP2Cm increases circulating BCAA and BCKA levels and enhances glucose tolerance and insulin sensitivity, regardless of the presence or absence of obesity and insulin resistance [52, 53]. The gene discussed is INS; the disease is Obesity.